Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

2017 FDA Science Forum Highlights Scientific Research

June 2, 2017—Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, highlighted the importance of scientific research during his May 31 remarks at the 2017 FDA Science Forum.

Commissioner Gottlieb stated that promoting creativity and efficiency, attracting top-quality scientists, and allowing them to conduct cutting-edge research are among his highest priorities. He noted that a major challenge in protecting public health is the increasing diversity and sophistication of new products.

He added that risks with novel approaches, such as gene therapy and gene editing, are a continued interest of the FDA. The FDA is formulating new guidance concerning regenerative medicine and seeks to advance standards in these areas to help move products forward. 

Contact:

Anne Berry, MPP
Lead Specialist, Implementation Research & Policy
Telephone: 202-739-2987
Email: aberry@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org